These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6811281

  • 1. Toxicity, antitumour and haematological effects of 1,2-anhydro-6-bromogalactitol and d-mannitol: a comparison with the related dibromo- and dianhydro-derivatives.
    Horváth IP, Somfai-Relle S, Hegedüs L, Jarman M.
    Eur J Cancer Clin Oncol; 1982 Jun; 18(6):573-7. PubMed ID: 6811281
    [Abstract] [Full Text] [Related]

  • 2. Clinical trials with the hexitol derivatives in the U.S.
    Chiuten DF, Rozencweig M, Von Hoff DD, Muggia FM.
    Cancer; 1981 Feb 01; 47(3):442-51. PubMed ID: 6784907
    [Abstract] [Full Text] [Related]

  • 3. Mutagenicity of dibromodulcitol (DBD), an alkylating anticancer drug) and its mono- and bifunctional conversion products studied by the Salmonella/microsome assay.
    Tóth K, Sugár J, Somfai-Relle S, Hedegüs L.
    Carcinogenesis; 1982 Feb 01; 3(3):333-6. PubMed ID: 7044598
    [Abstract] [Full Text] [Related]

  • 4. Effect of phenobarbital on the toxicity and antitumor activity of dibromodulcitol and dianhydrogalactitol.
    Gáti E, Somfai-Relle S.
    Arzneimittelforschung; 1982 Feb 01; 32(2):149-51. PubMed ID: 7199919
    [Abstract] [Full Text] [Related]

  • 5. Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
    Eckhardt S, Kerpel-Fronius S, Horváth IP, Institoris L.
    Gan To Kagaku Ryoho; 1985 Mar 01; 12(3 Pt 2):783-8. PubMed ID: 3985644
    [No Abstract] [Full Text] [Related]

  • 6. Rat liver-mediated degradation of dibromodulcitol.
    Csetényi J, Gáti E, Hegedüs L, Horváth IP, Holczinger L.
    Eur J Cancer Clin Oncol; 1985 Jul 01; 21(7):881-5. PubMed ID: 4043174
    [Abstract] [Full Text] [Related]

  • 7. Chemotherapeutic approaches to brain tumors. Experimental observations with dianhydrogalactitol and dibromodulcitol.
    Levin VA, Wheeler KT.
    Cancer Chemother Pharmacol; 1982 Jul 01; 8(1):125-31. PubMed ID: 7094198
    [Abstract] [Full Text] [Related]

  • 8. Hungarian anticancer drugs (antineoplastics).
    Kerpel-Fronius S.
    Ther Hung; 1982 Jul 01; 30(3):110-21. PubMed ID: 6095482
    [No Abstract] [Full Text] [Related]

  • 9. The effect of cytostatic hexitol derivatives on haematopoietic stem cells, the L1210 leukaemia and C22LR osteosarcoma.
    Fuzy M, Lelieveld P, Van Putten LM.
    Eur J Cancer (1965); 1975 Mar 01; 11(3):169-73. PubMed ID: 165939
    [No Abstract] [Full Text] [Related]

  • 10. Complex evaluation of the effect of some cytostatic hexitol derivatives.
    Holczinger L, Somfai-Relle S, Institoris E, Gáti E, Turi G.
    Oncology; 1980 Mar 01; 37 Suppl 1():104-8. PubMed ID: 7454197
    [Abstract] [Full Text] [Related]

  • 11. Potential antitumor agents. Some 1,6-disubstituted galactitol and mannitol derivatives.
    Acton EM, Keyanpour-Rad M, Christensen JE, Tong HH, Kwok RP, Goodman L.
    Carbohydr Res; 1972 May 01; 22(2):477-86. PubMed ID: 5047748
    [No Abstract] [Full Text] [Related]

  • 12. The effect of dibromo-dulcitol, diepoxy dulcitol and various new cytostatic hexitol derivatives on the metabolic activities of nucleic acids and proteins--II.
    Hidvégi EJ, Sebestyén J, Szabó LD, Köteles GJ, Institoris L.
    Biochem Pharmacol; 1976 Aug 01; 25(15):1705-10. PubMed ID: 942473
    [No Abstract] [Full Text] [Related]

  • 13. A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group B.
    Silver RT, Mick R, Cooper R, Ellison RR, Levy R, Brunner K, Schwartz JM, Holland JF.
    Cancer; 1987 Oct 01; 60(7):1442-8. PubMed ID: 3113712
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical pharmacology of carbohydrate derivatives with cytostatic potency.
    Eckhardt S.
    Adv Enzyme Regul; 1976 Oct 01; 14():297-311. PubMed ID: 788476
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man--II. pharmacokinetics of DBD.
    Horváth IP, Csetényi J, Hindy I, Kerpel-Fronius S, Institoris I, Hegedüs I, Eckhardt S.
    Eur J Cancer Clin Oncol; 1982 Nov 01; 18(11):1211-9. PubMed ID: 6891658
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical pharmacology of dibromohexitols.
    Eckhardt S.
    Haematologica; 1972 Apr 01; 57(11):722-31. PubMed ID: 4200307
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.